BR8907457A - INTERLEUCIN-1 INHIBITORS - Google Patents

INTERLEUCIN-1 INHIBITORS

Info

Publication number
BR8907457A
BR8907457A BR898907457A BR8907457A BR8907457A BR 8907457 A BR8907457 A BR 8907457A BR 898907457 A BR898907457 A BR 898907457A BR 8907457 A BR8907457 A BR 8907457A BR 8907457 A BR8907457 A BR 8907457A
Authority
BR
Brazil
Prior art keywords
interleucin
inhibitors
Prior art date
Application number
BR898907457A
Other languages
Portuguese (pt)
Inventor
Charles H Hannon
Stephen P Eisenberg
Robert C Thompson
William P Arend
Fenneke G Joslin
Andreas Sommer
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of BR8907457A publication Critical patent/BR8907457A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR898907457A 1988-05-27 1989-05-25 INTERLEUCIN-1 INHIBITORS BR8907457A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19991588A 1988-05-27 1988-05-27
US23871388A 1988-08-31 1988-08-31
US26653188A 1988-11-03 1988-11-03
PCT/US1989/002275 WO1989011540A1 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors

Publications (1)

Publication Number Publication Date
BR8907457A true BR8907457A (en) 1991-04-02

Family

ID=27394086

Family Applications (1)

Application Number Title Priority Date Filing Date
BR898907457A BR8907457A (en) 1988-05-27 1989-05-25 INTERLEUCIN-1 INHIBITORS

Country Status (9)

Country Link
JP (2) JP3192651B2 (en)
KR (1) KR970002917B1 (en)
BR (1) BR8907457A (en)
DK (1) DK172763B1 (en)
FI (2) FI109206B (en)
HU (3) HU9803037D0 (en)
NO (2) NO316122B1 (en)
OA (1) OA09631A (en)
WO (1) WO1989011540A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
ATE178094T1 (en) * 1990-05-01 1999-04-15 Chiron Corp INTERLEUKIN-I ANTAGONIST AND ITS USE
US5932537A (en) * 1990-10-09 1999-08-03 Chiron Corporation Method for attenuating a cellular response to IL-1
US5840496A (en) * 1990-10-09 1998-11-24 Chiron Corporation Method for diagnosing endometrial cancer
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
JP2005507915A (en) * 2001-10-26 2005-03-24 ノバルティス アクチエンゲゼルシャフト Method for treating osteoarthritis and composition thereof
AU2003243139B2 (en) 2002-04-05 2007-06-21 Amgen Inc. Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
EP2336177A1 (en) 2004-08-04 2011-06-22 Amgen, Inc Antibodies to DKK-1
JP5718640B2 (en) 2007-08-21 2015-05-13 アムジエン・インコーポレーテツド Human c-fms antigen binding protein
CN102209557A (en) * 2008-09-12 2011-10-05 埃克斯生物科技公司 Targeting pathogenic monocytes
WO2012025910A1 (en) 2010-08-26 2012-03-01 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS AT EARLY STAGES USING INTERLEUKIN IL-1ß AS EARLY BIOMARKER OF THE DISEASE
US9359405B2 (en) 2011-03-14 2016-06-07 Phlogo Aps Antagonists of the interleukin-1 receptor
AU2012242666A1 (en) 2011-04-15 2013-11-28 Merck Patent Gmbh Anti- IL-1R1 inhibitors for use in cancer
TW201605896A (en) 2013-08-30 2016-02-16 安美基股份有限公司 GITR antigen binding proteins
WO2015087187A1 (en) 2013-12-10 2015-06-18 Rinat Neuroscience Corp. Anti-sclerostin antibodies
CA3016894A1 (en) 2016-03-08 2017-09-14 Janssen Biotech, Inc. Gitr antibodies, methods, and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3014099B2 (en) * 1987-08-26 2000-02-28 バイオジェン インコーポレイテッド Biological materials, production of biological materials and methods of using such materials for therapy

Also Published As

Publication number Publication date
WO1989011540A1 (en) 1989-11-30
HU215434B (en) 1999-04-28
FI109206B (en) 2002-06-14
NO905090L (en) 1991-01-28
NO20014783L (en) 1991-01-28
DK8591A (en) 1991-01-18
NO905090D0 (en) 1990-11-23
NO20014783D0 (en) 2001-10-01
NO316917B1 (en) 2004-06-21
OA09631A (en) 1993-04-30
FI905812A0 (en) 1990-11-26
HU222810B1 (en) 2003-11-28
NO316122B1 (en) 2003-12-15
JP2001029093A (en) 2001-02-06
DK8591D0 (en) 1991-01-18
FI20020545A (en) 2002-03-21
DK172763B1 (en) 1999-07-05
AU633831B2 (en) 1993-02-11
JP3192651B2 (en) 2001-07-30
JPH03505279A (en) 1991-11-21
KR970002917B1 (en) 1997-03-12
HU893412D0 (en) 1991-05-28
AU3746989A (en) 1989-12-12
HU9803037D0 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
ATA901789A (en) SOMATOSTATINPEPTID
BR8806093A (en) TREPANO
ATA900689A (en) CALCITON INPEPTIDE
BR8907457A (en) INTERLEUCIN-1 INHIBITORS
FI101796B1 (en) New-glucosidase inhibitors
DE68926597D1 (en) MICROCALCULATOR
BR8902098A (en) ELECTRICIZER
DK113291A (en) HOMOGENT ENZYMIMMUNASSAY
BR8906898A (en) JAMELA
DK137889A (en) FOLDEAESKE
DK440989A (en) DOPAMINE-BETA-HYDROXYLASE INHIBITORS
DK69489A (en) ASPARTATTRANSCARBAMYLASE INHIBITORS
DK165575C (en) LOEFTESELE
DE68926367T2 (en) Hydroxymethylcyclobutylpurine
KR900004589U (en) long time
DD277186A3 (en) WAELZLAGERSEPARATOR
SE8800391D0 (en) STODBEN FOR STEGAR
BR8805477A (en) MILRAN TRANSPANTANEIRO
BR6800600U (en) HIDRO-SERRA
DK137688D0 (en) GAFFELLOEFTEVOGN
BR8803070A (en) RENDE-LAPIS
BR8801701A (en) ANTI-IVH
BR6802833U (en) SUBCALIBRATED MUNICATION - 90MM
BR6802550U (en) BICYCLE-SKATEBOARD
BR8806232A (en) BAU-CASA

Legal Events

Date Code Title Description
FA Application withdrawn
B15K Others concerning applications: alteration of classification

Ipc: C07K 16/18 (2006.01), C07K 14/54 (2006.0